Effect of gefitinib on warfarin antithrombotic activity

International Journal of Clinical Oncology

Volumn 14, Issue 4, 2009, Pages 332-336

  Arai, Susumu ^a,b   Mitsufuji, Hisashi ^a   Nishii, Yasuto ^a   Onoda, Sayaka ^a   Ryuge, Shinichiro ^a   Wada, Mayuko ^a   Katono, Ken ^a   Iwasaki, Maiko ^a   Takakura, Akira ^a   Otani, Sakiko ^a   Yamamoto, Michiko ^a   Yanaihara, Tomoko ^a   Yokoba, Masanori ^a   Kubota, Masaru ^a   Katagiri, Masato ^a   Fukui, Tomoya ^a   Kobayashi, Hirosuke ^a   Yanase, Nobuo ^a   Hataishi, Ryuji ^a   Masuda, Noriyuki ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Drug interaction; Gefitinib; Non small cell lung cancer; Prothrombin time international normalized ratio; Warfarin

Indexed keywords

GEFITINIB; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CANCER STAGING; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG EFFECT; EPISTAXIS; FEMALE; HEART ATRIUM FIBRILLATION; HEMATURIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER DYSFUNCTION; LIVER METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME;

AGED; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; BLOOD COAGULATION; CARCINOMA, NON-SMALL-CELL LUNG; DRUG INTERACTIONS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN KINASE INHIBITORS; PROTHROMBIN TIME; QUINAZOLINES; RETROSPECTIVE STUDIES; TIME FACTORS; WARFARIN;

EID: 69249185747     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-008-0871-2     Document Type: Article

References (18)

1. M.C. Brown 1999 An adverse interaction between warfarin and 5-fluorouracil: a case report and review of the literature Chemotherapy 45 392 395
2. M.H. Cohen G.A. Williams R. Sridhara 2004 United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets Clin Cancer Res 10 1212 1218
3. J.S. Cropp H.I. Bussey 1997 A review of enzyme induction of warfarin metabolism with recommendations for patient management Pharmacotherapy 17 917 928
4. J.-Y. Douillard E.S. Kim V. Hirsh 2007 Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non small cell lung cancer who have previously received platinum-based chemotherapy (INTEREST) Eur J Cancer 43 Suppl5 2
5. M. Fukuoka S. Yano G. Giaccone 2003 Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected] J Clin Oncol 21 2237 2246
6. G. Hall M.J. Lind M. Huang 1990 Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control Postgrad Med J 66 860 861
7. M.G. Kris R.B. Natale R.S. Herbst 2003 Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial JAMA 290 2149 2158
8. A.T. Le N.K. Hasson B.L. Lum 1997 Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy Ann Pharmacother 31 1006 1008
9. J. Li J. Brahmer W. Messersmith 2006 Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients Invest New Drugs 24 291 297
10. J. Marshall 2006 Clinical implications of the mechanism of epidermal growth factor receptor inhibitors Cancer 107 1207 1218
11. E.L. Michalets 1998 Update: clinically significant cytochrome P-450 drug interactions Pharmacotherapy 18 84 112
12. S.A. Mousa 2006 Role of current and emerging antithrombotics in thrombosis and cancer Drugs Today (Barc) 42 331 350
13. R.A. O'Reilly P.M. Aggeler L.S. Leong 1963 Studies on the coumarin anticoagulant drugs: the pharmacodynamics of warfarin in man J Clin Invest 42 1542 1551
14. S. Onoda H. Mitsufuji N. Yanase 2005 Drug interaction between gefitinib and warfarin Jpn J Clin Oncol 35 478 482
15. S. Sallah J.Y. Wan N.P. Nguyen 2002 Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 575 579
16. M.A. Scarfe M.K. Israel 1994 Possible drug interaction between warfarin and combination of levamisole and fluorouracil Ann Pharmacother 28 464 467
17. M.J. Serlin A.M. Breckenridge 1983 Drug interactions with warfarin Drugs 25 610 620
18. N. Thatcher A. Chang P. Parikh 2005 Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) Lancet 366 1527 1537